Biocardia announces japanese patent on imaging system for targeting cardiac therapies

San carlos, calif., july 15, 2021 (globe newswire) -- biocardia®, inc.  [nasdaq: bcda], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announces that the japan patent office has granted patent no: 6887216 titled, “target site selection, entry, and update with automatic remote image annotation” with a patent term that will expire on january 8, 2034.
BCDA Ratings Summary
BCDA Quant Ranking